Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Circulation
|
March 13, 2013
Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association
Laurie J Morrison, Robert W Neumar, Janice L Zimmerman, et al.
Mabs
|
May 25, 2023
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
Meghan M Verstraete, Florian Heinkel, Janessa Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease
Filip Pirsl, Lauren M Curtis, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
Jennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Blood
|
February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Blood
|
September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
James N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.
Physical Review Letters
|
July 28, 2023
^{133}In: A Rosetta Stone for Decays of r-Process Nuclei
Z Y Xu, M Madurga, R Grzywacz, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Circulation
|
March 13, 2013
Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association
Laurie J Morrison, Robert W Neumar, Janice L Zimmerman, et al.
Mabs
|
May 25, 2023
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
Meghan M Verstraete, Florian Heinkel, Janessa Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease
Filip Pirsl, Lauren M Curtis, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
Jennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Blood
|
February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Blood
|
September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
James N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.
Physical Review Letters
|
July 28, 2023
^{133}In: A Rosetta Stone for Decays of r-Process Nuclei
Z Y Xu, M Madurga, R Grzywacz, et al.
Page
of 4